Furthermore, it was found that NSCLC cells that were resistant to paclitaxel, a chemotherapeutic agent used in the treatment of lung cancer, had decreased FNDC5 levels, and irisin treatment was able to attenuate this chemoresistance [81]. Here, FNDC5 is linked to lung cancer.